摘要
目的:探讨活血化淤药物7643对细胞外间质合成的影响。方法:羟脯氨酸法、间接酶联免疫吸附法(ELISA)测定博莱霉素A6(BLMA6)诱发的小鼠、大鼠肺纤维化模型肺组织胶原含量及合成,阿利新蓝法测定其糖胺多糖(GAG)含量;3HPro掺入法测定体外培养兔角膜瘢痕成纤维细胞中胶原合成,ELISA测定其纤维粘连蛋白(Fn)含量。结果:7643对模型肺组织胶原合成有明显的抑制作用,抑制率50.5%,尤其能使肺组织中Ⅰ型胶原及GAG明显减少;体外实验证实,7643可抑制3HPro及3HTdR掺入成纤维细胞,且使其表面Fn明显减少。结论:7643抗纤维化作用机制的研究,应以细胞外间质组分———胶原合成为基点深入进行。
OBJECTIVE: To study the effect of Huoxue Huayu drug 764 3 on extracellular matrix (ECM). METHODS: Hydroproline determination and ELISA were used for measuring the content of collagen, Alcian blue assay for BLM-A6 induced glycosaminoglycan (GAG) in the lung tissues (rats, mice). Incorporation of 3 H Pro was used for determining the synthesis of collagen, ELISA for the fibronectin (Fn) in cultivated fibroblasts from the rabbit corneal stroma. RESULTS: 764 3 showed inhibition of collagen synthesis in the lung tissues of the animal model, and the inhibition rate was 50.5%. 764 3 as an active component of Huoxue Huayu drug resulted in apparent decrease of contents of collagen type Ⅰ and GAG. In cultivated fibroblasts, both the incorporation of 3 H Pro and the Fn content on surface of cells were significantly inhibited. CONCLUSION: Further research on anti fibrostic mechanism of Huoxue Huayu drug 764 3 should be taken on the basis of collagen biosynthesis.
出处
《中国药学杂志》
CAS
CSCD
北大核心
1997年第10期587-590,共4页
Chinese Pharmaceutical Journal
基金
中国医学科学院攻关项目基金
卫生部重点项目基金
关键词
胶原合成
活血化淤药物
764-3
extracellular matrix (ECM), collagen biosynthesis, Huoxue Huayu drug 764 3, pulmonary fibrosis, collagen